Steve Tutewohl - Jul 1, 2021 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role: Chief Operating Officer
Signature: /s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol: EVH
Transactions as of: Jul 1, 2021
Transactions value $: -$123,633
Form type: 4
Date filed: 7/2/2021, 04:37 PM
Next filing: Jul 12, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVH	Class A Common Stock	Options Exercise	$73.2K	+9.35K	+8.2%	$7.83	123K	Jul 1, 2021	Direct	F1, F2
transaction	EVH	Class A Common Stock	Sale	-$197K	-9.35K	-7.58%	$21.05	114K	Jul 1, 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVH	Class A Common Stock Option (right to buy)	Options Exercise	$0	-9.35K	-33.34%	$0.00	18.7K	Jul 1, 2021	Class A Common Stock	9.35K	$7.83	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
F2	Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 20.97 to $21.31, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The Class A Common Stock Options exercised vested on July 1, 2021.